Mixing compatibilities of Aspergillus and American cockroach allergens with other high-protease fungal and insect extracts.
暂无分享,去创建一个
[1] W. Reisacher,et al. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy , 2012, International forum of allergy & rhinology.
[2] R. Esch,et al. Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[3] T. Grier. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[4] L. Cox,et al. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[5] R. Esch,et al. Allergen compatibilities in extract mixtures. , 2011, Immunology and allergy clinics of North America.
[6] S. Spector,et al. Allergen immunotherapy: a practice parameter third update. , 2007, The Journal of allergy and clinical immunology.
[7] H. Nelson. Specific immunotherapy with allergen mixes: what is the evidence? , 2009, Current opinion in allergy and clinical immunology.
[8] R. Esch,et al. Stability and mixing compatibility of dog epithelia and dog dander allergens. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[9] A. Letz,et al. T-cell epitopes of aeroallergens. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[10] M. Tankersley,et al. Compatibility of imported fire ant whole body extract with cat, ragweed, Dermatophagoides pteronyssinus, and timothy grass allergens. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[11] R. Esch. Allergen immunotherapy: what can and cannot be mixed? , 2008, The Journal of allergy and clinical immunology.
[12] V. Duschak,et al. MALDI‐TOF MS analysis of labile Lolium perenne major allergens in mixes , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[13] R. Weber. Guidelines for using pollen cross-reactivity in formulating allergen immunotherapy. , 2008, The Journal of allergy and clinical immunology.
[14] J. Bousquet,et al. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. , 2008, Clinical allergy and immunology.
[15] Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter second update. , 2007 .
[16] R. Weber. Cross-reactivity of pollen allergens: impact on allergen immunotherapy. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] R. Esch,et al. Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[18] I. Bernstein. Allergen immunotherapy: a practice parameter second update. , 2007, The Journal of allergy and clinical immunology.
[19] M. Rathkopf,et al. Effect of imported fire ant extract on the degradation of mountain cedar pollen allergen. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[20] L. Bernstein,et al. Allergen immunotherapy: a practice parameter , 2003 .
[21] L. Hagan,et al. Factors affecting compliance with allergen immunotherapy at a military medical center. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[22] R. Esch,et al. Major allergen measurements: sources of variability, validation, quality assurance, and utility for laboratories, manufacturers, and clinics. , 2002, Allergy and asthma proceedings.
[23] S. Vieths,et al. Fusarium culmorum causes strong degradation of pollen allergens in extract mixtures. , 2002, The Journal of allergy and clinical immunology.
[24] T. Grier. Laboratory methods for allergen extract analysis and quality control , 2001, Clinical reviews in allergy & immunology.
[25] L. Vailes,et al. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. , 2001, The Journal of allergy and clinical immunology.
[26] B. Kurien,et al. Multiple immunoblots after non-electrophoretic bidirectional transfer of a single SDS-PAGE gel with multiple antigens. , 1997, Journal of immunological methods.
[27] J. Lamb,et al. T-cell responses to allergens: epitope-specificity and clinical relevance. , 1996, Immunology today.
[28] D. Ikle,et al. Studies of allergen extract stability: the effects of dilution and mixing. , 1996, The Journal of allergy and clinical immunology.
[29] J. Jones,et al. Effect of mixing allergenic extracts containing Helminthosporium, D. farinae, and cockroach with perennial ryegrass. , 1993, Annals of allergy.
[30] J. Salvaggio,et al. Protease activity in cockroach and basidiomycete allergen extracts. , 1993, Allergy proceedings : the official journal of regional and state allergy societies.
[31] J. Cohn,et al. Determinants of patient compliance with allergen immunotherapy. , 1993, The Journal of allergy and clinical immunology.
[32] R. Esch. Role of proteases on the stability of allergenic extracts. , 1992, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M.
[33] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.